Document
falsefalse--12-31--12-31Q1Q1201920192019-03-3110-Q00015745400001583994falsefalseLarge Accelerated FilerNon-accelerated FilerfalsefalseP1Y10.015000000001824160071843079101824160071843079100.007750.00850.0090.010.0110.01250.008250.0090.01450.01650.0110.0110.0125850000000750000001500000003500000004000000002500000000.04240.04740.04090.04030.03950.0430.023218241600718430791018241600718430791000518278451782915182784517829186000001800000P3YP2Y 0001574540 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember 2019-01-01 2019-03-31 0001574540 2019-04-24 0001574540 2019-03-31 0001574540 2018-12-31 0001574540 2018-01-01 2018-03-31 0001574540 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001574540 us-gaap:NoncontrollingInterestMember 2018-12-31 0001574540 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001574540 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001574540 2019-01-01 0001574540 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001574540 us-gaap:CommonStockMember 2018-12-31 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2019-01-01 2019-03-31 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-03-31 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-03-31 0001574540 us-gaap:ParentMember 2019-01-01 2019-03-31 0001574540 us-gaap:ParentMember 2019-01-01 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2019-01-01 2019-03-31 0001574540 us-gaap:CommonStockMember 2019-03-31 0001574540 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0001574540 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001574540 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0001574540 us-gaap:ParentMember 2019-03-31 0001574540 us-gaap:RetainedEarningsMember 2019-03-31 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-12-31 0001574540 us-gaap:ParentMember 2018-12-31 0001574540 us-gaap:NoncontrollingInterestMember 2019-03-31 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2018-12-31 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2019-03-31 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2019-03-31 0001574540 us-gaap:RetainedEarningsMember 2018-12-31 0001574540 2018-03-31 0001574540 us-gaap:ParentMember 2018-01-01 2018-03-31 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2018-01-01 2018-03-31 0001574540 us-gaap:NoncontrollingInterestMember 2017-12-31 0001574540 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-03-31 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-01-01 2018-03-31 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2018-03-31 0001574540 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001574540 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001574540 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001574540 us-gaap:CommonStockMember 2017-12-31 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0001574540 2017-12-31 0001574540 us-gaap:RetainedEarningsMember 2018-03-31 0001574540 us-gaap:RetainedEarningsMember 2017-12-31 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-12-31 0001574540 us-gaap:ParentMember 2018-03-31 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-31 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-03-31 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2017-12-31 0001574540 us-gaap:ParentMember 2017-12-31 0001574540 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001574540 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001574540 us-gaap:CommonStockMember 2018-03-31 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-03-31 0001574540 us-gaap:NoncontrollingInterestMember 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember 2018-12-31 0001574540 doc:PhysiciansRealtyLPMember 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember 2019-01-01 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2018-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2019-01-01 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2018-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2018-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2019-01-01 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2018-03-31 0001574540 doc:A2016ATMProgramMember srt:MaximumMember us-gaap:PrivatePlacementMember 2016-08-05 2016-08-05 0001574540 doc:PhysiciansRealtyLPMember doc:A2016ATMProgramMember us-gaap:PrivatePlacementMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:A2016ATMProgramMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2019-04-24 0001574540 doc:HealthEastClinicSpecialtyCenterMember 2019-03-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-03-31 0001574540 doc:HealthEastClinicSpecialtyCenterMember 2019-01-09 0001574540 doc:MezzanineLoanReceivableMember 2019-03-31 0001574540 us-gaap:ConstructionLoansMember 2019-03-31 0001574540 2018-01-09 2018-01-09 0001574540 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001574540 us-gaap:SeriesAPreferredStockMember 2015-02-05 0001574540 us-gaap:SeriesAPreferredStockMember 2015-02-05 2015-02-05 0001574540 doc:PhysiciansRealtyTrustMember 2019-01-01 2019-03-31 0001574540 doc:HealthEastClinicSpecialtyCenterMember 2019-01-01 2019-03-31 0001574540 doc:TermLoanReceivableMember 2019-03-31 0001574540 2019-03-22 2019-03-22 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2019-03-31 0001574540 doc:TermLoanMember 2019-01-01 2019-03-31 0001574540 us-gaap:RealEstateLoanMember 2019-03-31 0001574540 doc:TermLoanMember 2019-03-31 0001574540 doc:AcquiredLeaseIntangiblesMember 2019-03-31 0001574540 us-gaap:BuildingAndBuildingImprovementsMember 2019-03-31 0001574540 us-gaap:LandAndLandImprovementsMember 2019-03-31 0001574540 us-gaap:OtherAssetsMember 2019-03-31 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2019-01-01 2019-03-31 0001574540 doc:BelowMarketLeasesMember 2018-01-01 2018-03-31 0001574540 us-gaap:AboveMarketLeasesMember 2018-01-01 2018-03-31 0001574540 doc:BelowMarketGroundLeaseMember 2018-01-01 2018-03-31 0001574540 doc:BelowMarketLeasesMember 2019-01-01 2019-03-31 0001574540 us-gaap:AboveMarketLeasesMember 2019-01-01 2019-03-31 0001574540 doc:BelowMarketGroundLeaseMember 2019-01-01 2019-03-31 0001574540 doc:LeaseholdInterestMember 2019-01-01 2019-03-31 0001574540 doc:AboveMarketGroundLeaseMember 2018-01-01 2018-03-31 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2018-01-01 2018-03-31 0001574540 doc:AboveMarketGroundLeaseMember 2019-01-01 2019-03-31 0001574540 doc:LeaseholdInterestMember 2018-01-01 2018-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:BelowMarketGroundLeaseMember 2019-03-31 0001574540 doc:BelowMarketLeasesMember 2019-03-31 0001574540 doc:LeaseholdInterestMember 2018-12-31 0001574540 us-gaap:AboveMarketLeasesMember 2019-03-31 0001574540 us-gaap:AboveMarketLeasesMember 2018-12-31 0001574540 doc:BelowMarketLeasesMember 2018-12-31 0001574540 doc:OperatingLeaseRightofUseAssetsMember 2018-12-31 0001574540 doc:AboveMarketGroundLeaseMember 2019-03-31 0001574540 doc:BelowMarketGroundLeaseMember 2018-12-31 0001574540 doc:OperatingLeaseRightofUseAssetsMember 2019-03-31 0001574540 doc:LeaseholdInterestMember 2019-03-31 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2018-12-31 0001574540 doc:AboveMarketGroundLeaseMember 2018-12-31 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastAorA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastAorA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-01-01 2019-03-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueMarch2027Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember 2018-12-31 0001574540 doc:MortgageNotesBearingVariableInterestDue2028Member us-gaap:MortgagesMember 2018-12-31 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueMarch2027Member us-gaap:SeniorNotesMember 2018-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2028Member us-gaap:SeniorNotesMember 2018-12-31 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member us-gaap:MortgagesMember 2018-12-31 0001574540 doc:RevolvingCreditFacilityDueSeptember2022Member us-gaap:RevolvingCreditFacilityMember 2019-03-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member us-gaap:MortgagesMember 2019-03-31 0001574540 us-gaap:MortgagesMember 2019-03-31 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember 2019-03-31 0001574540 us-gaap:MortgagesMember 2018-12-31 0001574540 doc:MortgageNotesBearingVariableInterestDue2028Member us-gaap:MortgagesMember 2019-03-31 0001574540 doc:RevolvingCreditFacilityDueSeptember2022Member us-gaap:RevolvingCreditFacilityMember 2018-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2028Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2018-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2018-12-31 0001574540 doc:A2018CreditAgreementAmendmentMember 2018-08-07 0001574540 srt:MaximumMember doc:MortgageNotesBearingVariableInterestDue2028Member us-gaap:MortgagesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-03-31 0001574540 doc:A2018CreditAgreementAmendmentMember us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 srt:MaximumMember doc:A2018CreditAgreementAmendmentMember us-gaap:RevolvingCreditFacilityMember 2018-08-07 0001574540 doc:A2018CreditAgreementAmendmentMember 2019-01-01 2019-03-31 0001574540 us-gaap:LetterOfCreditMember 2019-03-31 0001574540 doc:SeniorNotesDue2023Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 srt:MinimumMember doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member us-gaap:MortgagesMember 2019-03-31 0001574540 us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:SenorNotesDue2031Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:A2018CreditAgreementAmendmentMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-07-07 0001574540 doc:TermLoanMember 2016-07-07 0001574540 doc:SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 us-gaap:RevolvingCreditFacilityMember 2019-03-31 0001574540 srt:MaximumMember doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member us-gaap:MortgagesMember 2019-03-31 0001574540 doc:TermLoanMember 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RevolvingCreditFacilityMember 2019-03-31 0001574540 doc:A2018CreditAgreementAmendmentMember doc:TermLoanMember 2018-08-07 2018-08-07 0001574540 doc:A2018CreditAgreementAmendmentMember doc:TermLoanMember 2018-08-07 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastAorA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:CreditratingatleastAorA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 srt:MinimumMember doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 srt:MinimumMember doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 srt:MaximumMember doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 srt:MaximumMember doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2019-03-31 0001574540 doc:RevolvingCreditFacilityDueSeptember2022Member us-gaap:RevolvingCreditFacilityMember 2019-01-01 2019-03-31 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 doc:RevolvingCreditFacilityDueSeptember2022Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-03-31 0001574540 us-gaap:RevolvingCreditFacilityMember 2019-01-01 2019-03-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2019-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2019-01-01 2019-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2018-12-31 0001574540 doc:PerformanceBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2019-03-01 2019-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2019-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2014-08-07 0001574540 doc:MarketConditionNumberTwoMember doc:MarketBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2019-03-01 2019-03-31 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2019-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember doc:TrusteesMember 2019-03-01 2019-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2014-08-07 2014-08-07 0001574540 doc:MarketBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2019-03-01 2019-03-31 0001574540 doc:PerformanceBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2019-03-01 2019-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2019-01-01 2019-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2013-12-31 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2019-01-01 2019-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember us-gaap:DirectorMember 2019-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2019-03-01 2019-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2018-01-01 2018-03-31 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2019-03-31 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2019-01-01 2019-03-31 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2018-12-31 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2018-12-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2019-03-01 2019-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2018-01-01 2018-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember doc:TrusteesMember 2018-03-01 2018-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2018-03-01 2018-03-31 0001574540 us-gaap:FairValueMeasurementsNonrecurringMember 2019-03-31 0001574540 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001574540 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-03-31 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001574540 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-03-31 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-03-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-03-31 0001574540 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-03-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001574540 doc:CHIPortfolioMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:TopfivetenantrelationshipsMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:RemainingPortfolioMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:NorthsideHospitalMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:BaylorScottandWhiteHealthMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:CHINebraskaMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:AscensionSt.VincentsIndianapolisMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 doc:CHIKentuckyOneHealthMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:GA 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember doc:AllotherstatesMember 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:TX 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:MN 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:NE 2019-01-01 2019-03-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:IN 2019-01-01 2019-03-31 0001574540 us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001574540 us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001574540 us-gaap:SubsequentEventMember 2019-04-04 2019-04-04 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember us-gaap:SubsequentEventMember 2019-04-26 2019-04-26 0001574540 us-gaap:SubsequentEventMember 2019-04-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember us-gaap:SubsequentEventMember 2019-04-03 2019-04-03 0001574540 us-gaap:SubsequentEventMember 2019-04-04 0001574540 doc:MezzanineLoanMember us-gaap:SubsequentEventMember 2019-04-16 doc:instruments doc:properties iso4217:USD xbrli:shares utreg:sqft xbrli:pure doc:segments xbrli:shares iso4217:USD doc:mezzanine_loan utreg:Rate doc:healthcareproperty
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
FORM 10-Q
 
 

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2019
 
or
 
☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from             to
 
Commission file number: 001-36007 (Physicians Realty Trust)
Commission file number: 333-205034-01 (Physicians Realty L.P.)
 
 
 
PHYSICIANS REALTY TRUST
PHYSICIANS REALTY L.P.
(Exact Name of Registrant as Specified in its Charter)
 
 
Maryland (Physicians Realty Trust)
Delaware (Physicians Realty L.P.)
(State of Organization)
 
46-2519850
80-0941870
(IRS Employer Identification No.)
 
 
 
309 N. Water Street,
Suite 500
Milwaukee, Wisconsin
(Address of Principal Executive Offices)
 
53202
(Zip Code)
 
(414) 367-5600
(Registrant’s Telephone Number, Including Area Code) 
 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Physicians Realty Trust        Yes ý No o            Physicians Realty L.P.        Yes ý No o    

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Physicians Realty Trust        Yes ý No o            Physicians Realty L.P.        Yes ý No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Physicians Realty Trust
Large accelerated filer ý     Accelerated filer o Non-accelerated filer o     Smaller reporting company o     Emerging growth company o

Physicians Realty L.P.
Large accelerated filer o     Accelerated filer o Non-accelerated filer ý     Smaller reporting company o     Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Physicians Realty Trust      o Physicians Realty L.P. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). 
Physicians Realty Trust        Yes o No ý         Physicians Realty L.P.        Yes o No ý

The number of Physicians Realty Trust’s common shares outstanding as of April 24, 2019 was 185,281,636.
 



EXPLANATORY NOTE

This Quarterly Report on Form 10-Q combines the Quarterly Reports on Form 10-Q for the quarter ended March 31, 2019 of Physicians Realty Trust (the “Trust”), a Maryland real estate investment trust, and Physicians Realty L.P. (the “Operating Partnership”), a Delaware limited partnership. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” and the “Company,” refer to the Trust, together with its consolidated subsidiaries, including the Operating Partnership. References to the “Operating Partnership” mean collectively the Operating Partnership, together with its consolidated subsidiaries. In this report, all references to “common shares” refer to the common shares of the Trust and references to “our shareholders” refer to shareholders of the common shares of the Trust, the term “OP Units” refers to partnership interests of the Operating Partnership and the term “Series A Preferred Units” refers to Series A Participating Redeemable Preferred Units of the Operating Partnership. As of April 24, 2019, 104,172 Series A Preferred Units were outstanding.

The Trust is a self-managed real estate investment trust (“REIT”) formed primarily to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. The Trust operates in an umbrella partnership REIT structure (“UPREIT”) in which the Operating Partnership and its subsidiaries hold substantially all of the assets. The Trust’s operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership. The Trust, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership.

The Trust conducts substantially all of its operations through the Operating Partnership. As of March 31, 2019, the Trust held a 97.3% interest in the Operating Partnership and owns no Series A Preferred Units. Apart from this ownership interest, the Trust has no independent operations.

Noncontrolling interests in the Operating Partnership, shareholders’ equity of the Trust, and partners’ capital of the Operating Partnership are the primary areas of difference between the consolidated financial statements of the Trust and those of the Operating Partnership. OP Units not owned by the Trust are accounted for as limited partners’ capital in the Operating Partnership’s consolidated financial statements and as noncontrolling interests in the Trust’s consolidated financial statements. The differences between the Trust’s shareholders’ equity and the Operating Partnership’s partners’ capital are due to the differences in the equity issued by the Trust and the Operating Partnership, respectively.

The Company believes combining the Quarterly Reports of the Trust and the Operating Partnership, including the notes to the consolidated financial statements, into this single report results in the following benefits:

a combined report enhances investors’ understanding of the Trust and the Operating Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;
a combined report eliminates duplicative disclosure and provides a more streamlined and readable presentation, as a substantial portion of the Company’s disclosure applies to both the Trust and the Operating Partnership; and
a combined report creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.

To help investors understand the significant differences between the Trust and the Operating Partnership, this report presents the following separate sections for each of the Trust and the Operating Partnership:

the consolidated financial statements in Part I, Item 1 of this report;
certain accompanying notes to the consolidated financial statements, including Note 14 (Earnings Per Share and Earnings Per Unit);
controls and procedures in Part I, Item 4 of this report; and
the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this report.



Table of Contents

PHYSICIANS REALTY TRUST AND PHYSICIANS REALTY L.P.
 
Quarterly Report on Form 10-Q
for the Quarter Ended March 31, 2019
 
Table of Contents
 
 

 
 
Page Number
 
 
 
 
 
 
 
 
Financial Statements of Physicians Realty Trust
 
 
 
 
 
 
 
 
 
Financial Statements of Physicians Realty L.P.
 
 
 
 
 
 
 
 
 
Notes for Physicians Realty Trust and Physicians Realty L.P.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
This Quarterly Report on Form 10-Q contains forward-looking statements made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts may be forward-looking statements within the meaning of the federal securities laws. In particular, statements pertaining to our capital resources, property performance and results of operations contain forward-looking statements. Likewise, all of our statements regarding anticipated growth in our funds from operations and anticipated market conditions, demographics and results of operations are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as “believe,” “expect,” “outlook,” “continue,” “project,” “may,” “will,” “should,” “seek,” “approximately,” “intend,” “plan,” “pro forma,” “estimate” or “anticipate” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans, expectations, or intentions.
 
These forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information. These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data, or methods which may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:
 
general economic conditions;

adverse economic or real estate developments, either nationally or in the markets where our properties are located;

our failure to generate sufficient cash flows to service our outstanding indebtedness, or our ability to pay down or refinance our indebtedness;

fluctuations in interest rates and increased operating costs;

the availability, terms and deployment of debt and equity capital, including our unsecured revolving credit facility;

our ability to make distributions on our common shares;

general volatility of the market price of our common shares;

our increased vulnerability economically due to the concentration of our investments in healthcare properties;

our geographic concentration in Texas causes us to be particularly exposed to downturns in the Texas economy or other changes in Texas market conditions;

changes in our business or strategy;

our dependence upon key personnel whose continued service is not guaranteed;

our ability to identify, hire, and retain highly qualified personnel in the future;

the degree and nature of our competition;

changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates, taxation of REITs, and similar matters;

defaults on or non-renewal of leases by tenants;

decreased rental rates or increased vacancy rates;
 
difficulties in identifying healthcare properties to acquire and completing acquisitions;

competition for investment opportunities;

1

Table of Contents

any adverse effects to the business, financial position or results of CommonSpirit Health, or one or more of the CommonSpirit Health-affiliated tenants, that impact the ability of CommonSpirit Health-affiliated tenants to pay us rent;

the impact of our investments in joint ventures we may make in the future;

the financial condition and liquidity of, or disputes with, any joint venture and development partners with whom we may make co-investments in the future;

cybersecurity incidents could disrupt our business and result in the compromise of confidential information;

our ability to operate as a public company;

changes in healthcare laws or government reimbursement rates;

changes in accounting principles generally accepted in the United States (“GAAP”);

lack of or insufficient amounts of insurance;

other factors affecting the real estate industry generally;

our failure to maintain our qualification as a REIT for U.S. federal income tax purposes;

limitations imposed on our business and our ability to satisfy complex rules in order for us to qualify as a REIT for U.S. federal income tax purposes; and

other factors that may materially adversely affect us, or the per share trading price of our common shares, including:
 
the number of our common shares available for future issuance or sale;
our issuance of equity securities or the perception that such issuance might occur;
future debt;
failure of securities analysts to publish research or reports about us or our industry; and
securities analysts’ downgrade of our common shares or the healthcare-related real estate sector.

While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. We disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events, or other changes after the date of this report, except as required by applicable law. You should not place undue reliance on any forward-looking statements that are based on information currently available to us or the third parties making the forward-looking statements. For a further discussion of these and other factors that could impact our future results, performance or transactions, see Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Annual Report”).

2

Table of Contents

PART I.                         Financial Information
Item 1.                             Financial Statements
Physicians Realty Trust
Consolidated Balance Sheets
(In thousands, except share and per share data)
 
March 31,
2019
 
December 31,
2018
 
(unaudited)
 
 
ASSETS
 

 
 

Investment properties:
 

 
 

Land and improvements
$
210,542

 
$
211,253

Building and improvements
3,627,825

 
3,623,962

Tenant improvements
43,213

 
36,497

Acquired lease intangibles
386,707

 
452,384

 
4,268,287


4,324,096

Accumulated depreciation
(443,814
)
 
(411,052
)
Net real estate property
3,824,473


3,913,044

Real estate held for sale
9,038

 

Right-of-use lease asset, net
126,250

 

Real estate loans receivable
75,474

 
55,659

Investments in unconsolidated entities
1,331

 
1,330

Net real estate investments
4,036,566


3,970,033

Cash and cash equivalents
5,048

 
19,161

Tenant receivables, net
10,566

 
8,881

Other assets
132,825

 
144,759

Total assets
$
4,185,005


$
4,142,834

LIABILITIES AND EQUITY
 

 
 

Liabilities:
 

 
 

Credit facility
$
478,892

 
$
457,388

Notes payable
967,161

 
966,961

Mortgage debt
99,608

 
108,504

Accounts payable
3,513

 
3,886

Dividends and distributions payable
44,335

 
43,821

Accrued expenses and other liabilities
56,088

 
76,282

Lease liability
60,864

 

Acquired lease intangibles, net
7,336

 
13,585

Total liabilities
1,717,797


1,670,427

 
 
 
 
Redeemable noncontrolling interest - Series A Preferred Units and partially owned properties
24,882

 
24,747

 
 
 
 
Equity:
 

 
 

Common shares, $0.01 par value, 500,000,000 common shares authorized, 184,307,910 and 182,416,007 common shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
1,843

 
1,824

Additional paid-in capital
2,822,520

 
2,791,555

Accumulated deficit
(460,357
)
 
(428,307
)
Accumulated other comprehensive income
10,957

 
14,433

Total shareholders’ equity
2,374,963


2,379,505

Noncontrolling interests:
 

 
 

Operating Partnership
66,668

 
67,477

Partially owned properties
695

 
678

Total noncontrolling interests
67,363


68,155

Total equity
2,442,326


2,447,660

Total liabilities and equity
$
4,185,005


$
4,142,834

The accompanying notes are an integral part of these consolidated financial statements.

3

Table of Contents

Physicians Realty Trust
Consolidated Statements of Income
(In thousands, except share and per share data) (Unaudited)
 
Three Months Ended
March 31,
 
2019
 
2018
Revenues:
 

 
 

Rental revenues
$
77,083

 
$
78,887

Expense recoveries
26,042

 
24,308

Interest income on real estate loans and other
2,243

 
2,028

Total revenues
105,368


105,223

Expenses:
 

 
 

Interest expense
16,269

 
16,494

General and administrative
8,972

 
8,459

Operating expenses
32,208

 
30,459

Depreciation and amortization
36,449

 
38,576

Total expenses
93,898


93,988

Income before equity in income of unconsolidated entities and gain on sale of investment properties, net:
11,470

 
11,235

Equity in income of unconsolidated entities
30

 
28

Gain on sale of investment properties, net

 
69

Net income
11,500


11,332

Net income attributable to noncontrolling interests:
 

 
 

Operating Partnership
(305
)
 
(313
)
Partially owned properties (1)
(138
)
 
(111
)
Net income attributable to controlling interest
11,057


10,908

Preferred distributions
(284
)
 
(487
)
Net income attributable to common shareholders
$
10,773


$
10,421

Net income per share:
 

 
 

Basic
$
0.06

 
$
0.06

Diluted
$
0.06

 
$
0.06

Weighted average common shares:
 

 
 

Basic
182,672,863

 
181,809,570

Diluted
188,497,308

 
187,317,243

 
 
 
 
Dividends and distributions declared per common share and OP Unit
$
0.23

 
$
0.23

(1)
Includes amounts attributable to redeemable noncontrolling interests.

The accompanying notes are an integral part of these consolidated financial statements.

4

Table of Contents

Physicians Realty Trust
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
 
Three Months Ended
March 31,
 
2019
 
2018
Net income
$
11,500

 
$
11,332

Other comprehensive income:
 
 
 
Change in fair value of interest rate swap agreements, net
(3,476
)
 
4,298

Total other comprehensive income
(3,476
)
 
4,298

Comprehensive income
8,024

 
15,630

Comprehensive income attributable to noncontrolling interests - Operating Partnership
(210
)
 
(438
)
Comprehensive income attributable to noncontrolling interests - partially owned properties
(138
)
 
(111
)
Comprehensive income attributable to common shareholders
$
7,676

 
$
15,081


The accompanying notes are an integral part of these consolidated financial statements.

5

Table of Contents

Physicians Realty Trust
Consolidated Statements of Equity
(In thousands) (Unaudited)

 
Par
Value
 
Additional
Paid in
Capital
 
Accumulated
Deficit
 
Accumulated Other Comprehensive Income
 
Total
Shareholders’ 
Equity
 
Operating
Partnership
Noncontrolling
Interest
 
Partially
Owned
Properties 
Noncontrolling
Interest
 
Total
Noncontrolling
Interests
 
Total
Equity
Balance at December 31, 2018
$
1,824

 
$
2,791,555

 
$
(428,307
)
 
$
14,433

 
$
2,379,505

 
$
67,477

 
$
678

 
$
68,155

 
$
2,447,660

Cumulative effect of changes in accounting standard

 
(239
)
 

 

 
(239
)
 

 

 

 
(239
)
Net proceeds from sale of common shares
17

 
31,003

 

 

 
31,020

 

 

 

 
31,020

Restricted share award grants, net
2

 
640

 
(287
)
 

 
355

 

 

 

 
355

Purchase of OP Units

 

 

 

 

 
(105
)
 

 
(105
)
 
(105
)
Dividends/distributions declared

 

 
(42,536
)
 

 
(42,536
)
 
(1,158
)
 

 
(1,158
)
 
(43,694
)
Preferred distributions

 

 
(284
)
 

 
(284
)
 

 

 

 
(284
)
Distributions

 

 

 

 

 

 
(47
)
 
(47
)
 
(47
)
Change in market value of Redeemable Noncontrolling Interest in Operating Partnership

 
(290
)
 

 

 
(290
)
 

 

 

 
(290
)
Change in fair value of interest rate swap agreements

 

 

 
(3,476
)
 
(3,476
)
 

 

 

 
(3,476
)
Net income

 

 
11,057

 

 
11,057

 
305

 
64

 
369

 
11,426

Adjustment for Noncontrolling Interests ownership in Operating Partnership

 
(149
)
 

 

 
(149
)
 
149

 

 
149

 

Balance at March 31, 2019
$
1,843

 
$
2,822,520

 
$
(460,357
)
 
$
10,957

 
$
2,374,963

 
$
66,668

 
$
695

 
$
67,363

 
$
2,442,326


The accompanying notes are an integral part of these consolidated financial statements.


6

Table of Contents

Physicians Realty Trust
Consolidated Statements of Equity
(In thousands) (Unaudited)

 
Par
Value
 
Additional
Paid in
Capital
 
Accumulated
Deficit
 
Accumulated Other Comprehensive Income
 
Total
Shareholders’ 
Equity
 
Operating
Partnership
Noncontrolling
Interest
 
Partially
Owned
Properties 
Noncontrolling
Interest
 
Total
Noncontrolling
Interests
 
Total
Equity
Balance at December 31, 2017
$
1,814

 
$
2,772,823

 
$
(315,417
)
 
$
13,952

 
$
2,473,172

 
$
73,844

 
$
618

 
$
74,462

 
$
2,547,634

Net proceeds from sale of common shares
3

 
5,313

 

 

 
5,316

 

 

 

 
5,316

Restricted share award grants, net
2

 
872

 
59

 

 
933

 

 

 

 
933

Conversion of OP Units

 
126

 

 

 
126

 
(126
)
 

 
(126
)
 

Dividends/distributions declared

 

 
(41,910
)
 

 
(41,910
)
 
(1,216
)
 

 
(1,216
)
 
(43,126
)
Preferred distributions

 

 
(487
)
 

 
(487
)
 

 

 

 
(487
)
Distributions

 

 

 

 

 

 
(43
)
 
(43
)
 
(43
)
Change in market value of Redeemable Noncontrolling Interest in Operating Partnership

 
194

 
1,276

 

 
1,470

 

 

 

 
1,470

Change in fair value of interest rate swap agreements

 

 

 
4,298

 
4,298

 

 

 

 
4,298

Net income

 

 
10,908

 

 
10,908

 
313

 
44

 
357

 
11,265

Adjustment for Noncontrolling Interests ownership in Operating Partnership

 
(712
)
 

 

 
(712
)
 
712

 

 
712

 

Balance at March 31, 2018
$
1,819

 
$
2,778,616

 
$
(345,571
)
 
$
18,250

 
$
2,453,114

 
$
73,527

 
$
619

 
$
74,146

 
$
2,527,260


The accompanying notes are an integral part of these consolidated financial statements.


7

Table of Contents

Physicians Realty Trust
Consolidated Statements of Cash Flows
(In thousands) (Unaudited)
 
Three Months Ended
March 31,
 
2019
 
2018
Cash Flows from Operating Activities:
 

 
 

Net income
$
11,500

 
$
11,332

Adjustments to reconcile net income to net cash provided by operating activities
 
 
 

Depreciation and amortization
36,449

 
38,576

Amortization of deferred financing costs
607

 
618

Amortization of lease inducements and above/below-market lease intangibles
1,176

 
1,190

Straight-line rental revenue/expense
(4,762
)
 
(6,450
)
Amortization of discount on unsecured senior notes
148

 
142

Amortization of above market assumed debt
(16
)
 
(16
)
Gain on sale of investment properties, net

 
(69
)
Equity in income of unconsolidated entities
(30
)
 
(28
)
Distributions from unconsolidated entities
29

 
26

Change in fair value of derivative
13

 
2

Provision for bad debts
35

 
(141
)
Non-cash share compensation
2,653

 
2,605

Change in operating assets and liabilities:
 

 
 

Tenant receivables
(2,076
)
 
5,437

Other assets
647

 
(222
)
Accounts payable
(373
)
 
(8,461
)
Accrued expenses and other liabilities
(19,573
)
 
(3,651
)
Net cash provided by operating activities
26,427


40,890

Cash Flows from Investing Activities:
 

 
 

Proceeds on sales of investment properties

 
2,440

Acquisition of investment properties, net
(4,303
)
 
(84,202
)
Escrowed cash - acquisition deposits/earnest deposits
(150
)
 
(2,720
)
Capital expenditures on investment properties
(12,953
)
 
(5,608
)
Issuance of real estate loans receivable
(20,028
)
 
(2,000
)
Repayment of real estate loans receivable
325

 
6,717

Issuance of note receivable

 
(20,385
)
Leasing commissions
(552
)
 
(664
)
Lease inducements
(5
)
 

Net cash used in investing activities
(37,666
)

(106,422
)
Cash Flows from Financing Activities:
 

 
 

Net proceeds from sale of common shares
31,020

 
5,316

Proceeds from credit facility borrowings
68,000

 
166,000

Repayment of credit facility borrowings
(47,000
)
 
(24,000
)
Principal payments on mortgage debt
(8,908
)
 
(32,157
)
Debt issuance costs
(8
)
 
(412
)
Dividends paid - shareholders
(42,301
)
 
(42,251
)
Distributions to noncontrolling interests - Operating Partnership
(1,167
)
 
(1,232
)
Preferred distributions paid - OP Unit holder
(284
)
 
(81
)
Distributions to noncontrolling interests - partially owned properties
(148
)
 
(127
)
Payments of employee taxes for withheld stock-based compensation shares
(1,973
)
 
(1,701
)
Purchase of OP Units
(105
)
 

Net cash (used in) provided by financing activities
(2,874
)

69,355

Net (decrease) increase in cash and cash equivalents
(14,113
)
 
3,823

Cash and cash equivalents, beginning of period
19,161

 
2,727

Cash and cash equivalents, end of period
$
5,048


$
6,550

Supplemental disclosure of cash flow information - interest paid during the period
$
25,799

 
$
19,230

Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements
$
(3,476
)
 
$
4,298

Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions
$

 
$
22,651

The accompanying notes are an integral part of these consolidated financial statements.

8

Table of Contents

Physicians Realty L.P.
Consolidated Balance Sheets
(In thousands, except unit and per unit data)
 
March 31,
2019
 
December 31, 2018
 
(unaudited)
 
 
ASSETS
 

 
 

Investment properties:
 
 
 
Land and improvements
$
210,542

 
$
211,253

Building and improvements
3,627,825

 
3,623,962

Tenant improvements
43,213

 
36,497

Acquired lease intangibles
386,707

 
452,384

 
4,268,287

 
4,324,096

Accumulated depreciation
(443,814
)
 
(411,052
)
Net real estate property
3,824,473

 
3,913,044

Real estate held for sale
9,038

 

Right-of-use lease asset, net
126,250

 

Real estate loans receivable
75,474

 
55,659

Investments in unconsolidated entities
1,331

 
1,330

Net real estate investments
4,036,566

 
3,970,033

Cash and cash equivalents
5,048

 
19,161

Tenant receivables, net
10,566

 
8,881

Other assets
132,825

 
144,759

Total assets
$
4,185,005

 
$
4,142,834

LIABILITIES AND CAPITAL
 
 
 
Liabilities:
 
 
 
Credit facility
$
478,892

 
$
457,388

Notes payable
967,161

 
966,961

Mortgage debt
99,608

 
108,504

Accounts payable
3,513

 
3,886

Distributions payable
44,335

 
43,821

Accrued expenses and other liabilities
56,088

 
76,282

Lease liability
60,864

 

Acquired lease intangibles, net
7,336

 
13,585

Total liabilities
1,717,797

 
1,670,427

 
 
 
 
Redeemable noncontrolling interest - Series A Preferred Units and partially owned properties
24,882

 
24,747

 
 
 
 
Capital:
 
 
 
Partners’ capital:
 
 
 
General partners’ capital, 184,307,910 and 182,416,007 units issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
2,364,006

 
2,365,072

Limited partners’ capital, 5,178,291 and 5,182,784 units issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
66,668

 
67,477

Accumulated other comprehensive income
10,957

 
14,433

Total partners’ capital
2,441,631

 
2,446,982

Noncontrolling interest - partially owned properties
695

 
678

Total capital
2,442,326

 
2,447,660

Total liabilities and capital
$
4,185,005

 
$
4,142,834


The accompanying notes are an integral part of these consolidated financial statements.


9

Table of Contents

Physicians Realty L.P.
Consolidated Statements of Income
(In thousands, except unit and per unit data) (Unaudited)
 
Three Months Ended
March 31,
 
2019
 
2018
Revenues:
 

 
 

Rental revenues
$
77,083

 
$
78,887

Expense recoveries
26,042

 
24,308

Interest income on real estate loans and other
2,243

 
2,028

Total revenues
105,368

 
105,223

Expenses:
 
 
 
Interest expense
16,269

 
16,494

General and administrative
8,972

 
8,459

Operating expenses
32,208

 
30,459

Depreciation and amortization
36,449

 
38,576

Total expenses
93,898

 
93,988

Income before equity in income of unconsolidated entities and gain on sale of investment properties, net:
11,470

 
11,235

Equity in income of unconsolidated entities
30

 
28

Gain on sale of investment properties, net

 
69

Net income
11,500

 
11,332

Net income attributable to noncontrolling interests - partially owned properties (1)
(138
)
 
(111
)
Net income attributable to controlling interest
11,362

 
11,221

Preferred distributions
(284
)
 
(487
)
Net income attributable to common unitholders
$
11,078

 
$
10,734

Net income per common unit:
 
 
 
Basic
$
0.06

 
$
0.06

Diluted
$
0.06

 
$
0.06

Weighted average common units:
 
 
 
Basic
187,850,775

 
187,264,064

Diluted
188,497,308

 
187,317,243

 
 
 
 
Distributions declared per common unit
$
0.23

 
$
0.23

(1)
Includes amounts attributable to redeemable noncontrolling interests.

The accompanying notes are an integral part of these consolidated financial statements.


10

Table of Contents

Physicians Realty L.P.
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
 
Three Months Ended
March 31,
 
2019
 
2018
Net income
$
11,500

 
$
11,332

Other comprehensive income:
 
 
 
Change in fair value of interest rate swap agreements, net
(3,476
)
 
4,298

Total other comprehensive income
(3,476
)
 
4,298

Comprehensive income
8,024

 
15,630

Comprehensive income attributable to noncontrolling interests - partially owned properties
(138
)
 
(111
)
Comprehensive income attributable to common unitholders
$
7,886

 
$
15,519


The accompanying notes are an integral part of these consolidated financial statements.


11

Table of Contents

Physicians Realty L.P.
Consolidated Statements of Changes in Capital
(In thousands) (Unaudited)

 
General Partner
 
Limited Partner
 
Accumulated Other Comprehensive Income
 
Total
Partners’ Capital
 
Partially
Owned
Properties
Noncontrolling
Interest
 
Total Capital
Balance at December 31, 2018
$
2,365,072

 
$
67,477

 
$
14,433

 
$
2,446,982

 
$
678

 
$
2,447,660

Cumulative effect of changes in accounting standard
(239
)
 

 

 
(239
)
 

 
(239
)
Net Proceeds from sale of Trust common shares and issuance of common units
31,020

 

 

 
31,020

 

 
31,020

Trust restricted share award grants, net
355

 

 

 
355

 

 
355

Purchase of OP Units

 
(105
)
 

 
(105
)
 

 
(105
)
OP Units - distributions
(42,536
)
 
(1,158
)
 

 
(43,694
)
 

 
(43,694
)
Preferred distributions
(284
)
 

 

 
(284
)
 

 
(284
)
Distributions

 

 

 

 
(47
)
 
(47
)
Change in market value of Redeemable Limited Partners
(290
)
 

 

 
(290
)
 

 
(290
)
Change in fair value of interest rate swap agreements

 

 
(3,476
)
 
(3,476
)
 

 
(3,476
)
Net income
11,057

 
305

 

 
11,362

 
64

 
11,426

Adjustments for Limited Partners ownership in Operating Partnership
(149
)
 
149

 

 

 

 

Balance at March 31, 2019
$
2,364,006

 
$
66,668

 
$
10,957

 
$
2,441,631

 
$
695

 
$
2,442,326


 The accompanying notes are an integral part of these consolidated financial statements.

12

Table of Contents


Physicians Realty L.P.
Consolidated Statements of Changes in Capital
(In thousands) (Unaudited)

 
General Partner
 
Limited Partner
 
Accumulated Other Comprehensive Income
 
Total
Partners’ Capital
 
Partially
Owned
Properties
Noncontrolling
Interest
 
Total Capital
Balance at December 31, 2017
$
2,459,220

 
$
73,844

 
$
13,952

 
$
2,547,016

 
$
618

 
$
2,547,634

Net Proceeds from sale of Trust common shares and issuance of common units
5,316

 

 

 
5,316

 

 
5,316

Trust restricted share award grants, net
933

 

 

 
933

 

 
933

Conversion of OP Units
126